{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T02:42:25Z","timestamp":1770777745941,"version":"3.50.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fili\u00e8re maladies rares en dermatologie"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36295-7","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:38:18Z","timestamp":1768631898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Consensus for the most suitable trial design to assess therapy for rare vascular malformations: a Delphi study"],"prefix":"10.1038","volume":"16","author":[{"given":"Aude","family":"Allemang-Trivalle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Giraudeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel","family":"Maruani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"36295_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s13063-017-2287-7","volume":"18","author":"A Rath","year":"2017","unstructured":"Rath, A. et al. A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome? Trials 18, 556 (2017).","journal-title":"Trials"},{"key":"36295_CR2","unstructured":"Rare diseases - European Commission  (2024). https:\/\/health.ec.europa.eu\/european-reference-networks\/rare-diseases_en."},{"key":"36295_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejrad.2004.07.023","volume":"53","author":"S Puig","year":"2005","unstructured":"Puig, S., Casati, B., Staudenherz, A. & Paya, K. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur. J. Radiol. 53, 35\u201345 (2005).","journal-title":"Eur. J. Radiol."},{"key":"36295_CR4","unstructured":"The European Parliament and the Council of the European Union. Regulation (EC) No 141\/2000 of The European Parliament and of The Council of 16 December 1999 on Orphan Medicinal Products. 0001\u20130005  (2000)."},{"key":"36295_CR5","unstructured":"97th Congress, 2nd Session. Orphan Drug Act of 1983. Pub L. No. 97\u2013414, 96 Stat. 2049. vol. 96 2049\u20132066 (1983)."},{"key":"36295_CR6","first-page":"3","volume":"1","author":"P Song","year":"2012","unstructured":"Song, P., Gao, J., Inagaki, Y., Kokudo, N. & Tang, W. Rare diseases, orphan drugs, and their regulation in asia: current status and future perspectives. Intractable Rare Dis. Res. 1, 3\u20139 (2012).","journal-title":"Intractable Rare Dis. Res."},{"key":"36295_CR7","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","volume":"136","author":"M Wassef","year":"2015","unstructured":"Wassef, M. et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics 136, e203\u2013214 (2015).","journal-title":"Pediatrics"},{"key":"36295_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jamaoto.2020.4353","volume":"147","author":"SC Gallant","year":"2021","unstructured":"Gallant, S. C., Chewning, R. H., Orbach, D. B., Trenor, C. C. & Cunningham, M. J. Contemporary management of vascular anomalies of the head and Neck-Part 1: vascular malformations: a review. JAMA Otolaryngol. -- Head Neck Surg. 147, 197\u2013206 (2021).","journal-title":"JAMA Otolaryngol. -- Head Neck Surg."},{"key":"36295_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ajmg.a.36836","volume":"167A","author":"KM Keppler-Noreuil","year":"2015","unstructured":"Keppler-Noreuil, K. M. et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am. J. Med. Genet. A. 167A, 287\u2013295 (2015).","journal-title":"Am. J. Med. Genet. A"},{"key":"36295_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jamadermatol.2018.0002","volume":"154","author":"HL Nguyen","year":"2018","unstructured":"Nguyen, H. L., Bonadurer, G. F. & Tollefson, M. M. Vascular malformations and Health-Related quality of life: a systematic review and Meta-analysis. JAMA Dermatol. 154, 661\u2013669 (2018).","journal-title":"JAMA Dermatol."},{"key":"36295_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13063-018-2725-1","volume":"19","author":"A Maruani","year":"2018","unstructured":"Maruani, A. et al. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design. Trials 19, 340 (2018).","journal-title":"Trials"},{"issue":"Suppl 1","key":"36295_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00228-011-0990-y","volume":"67","author":"P Baiardi","year":"2011","unstructured":"Baiardi, P. et al. Innovative study design for paediatric clinical trials. Eur. J. Clin. Pharmacol. 67 (Suppl 1), 109\u2013115 (2011).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"36295_CR13","doi-asserted-by":"crossref","unstructured":"Jacqz-Aigrain, E. & Choonara, I. Paediatric Clinical Pharmacology (Taylor & Francis, 2006).","DOI":"10.1201\/b14101"},{"key":"36295_CR14","doi-asserted-by":"publisher","first-page":"105852","DOI":"10.1016\/j.cct.2019.105852","volume":"86","author":"Y Park","year":"2019","unstructured":"Park, Y., Fullerton, H. J. & Elm, J. J. A pragmatic, adaptive clinical trial design for a rare disease: the focal cerebral arteriopathy steroid (FOCAS) trial. Contemp. Clin. Trials. 86, 105852 (2019).","journal-title":"Contemp. Clin. Trials"},{"key":"36295_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1172-3-11","volume":"3","author":"SC Chow","year":"2008","unstructured":"Chow, S. C. & Chang, M. Adaptive design methods in clinical trials - a review. Orphanet J. Rare Dis. 3, 11 (2008).","journal-title":"Orphanet J. Rare Dis."},{"key":"36295_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.70083","author":"R Krishna","year":"2025","unstructured":"Krishna, R., Mitra, A., Zierhut, M. L., East, L. & Durairaj, C. State-of-the-Art on Model-Informed drug development approaches for pediatric rare diseases. CPT Pharmacomet. Syst. Pharmacol. https:\/\/doi.org\/10.1002\/psp4.70083 (2025).","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"36295_CR17","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1002\/sim.6225","volume":"33","author":"LV Hampson","year":"2014","unstructured":"Hampson, L. V., Whitehead, J., Eleftheriou, D. & Brogan, P. Bayesian methods for the design and interpretation of clinical trials in very rare diseases. Stat. Med. 33, 4186\u20134201 (2014).","journal-title":"Stat. Med."},{"key":"36295_CR18","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.21037\/atm-21-5496","volume":"10","author":"Y Li","year":"2022","unstructured":"Li, Y. & Izem, R. Novel clinical trial design and analytic methods to tackle challenges in therapeutic development in rare diseases. Ann. Transl. Med. 10, 1034 (2022).","journal-title":"Ann. Transl. Med."},{"key":"36295_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/1740774515626362","volume":"13","author":"BR Saville","year":"2016","unstructured":"Saville, B. R. & Berry, S. M. Efficiencies of platform clinical trials: a vision of the future. Clin. Trials Lond. Engl. 13, 358\u2013366 (2016).","journal-title":"Clin. Trials Lond. Engl."},{"key":"36295_CR20","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/1346-8138.17688","volume":"52","author":"M Jinnin","year":"2025","unstructured":"Jinnin, M. et al. Topical sirolimus therapy for cutaneous vascular anomalies: a randomized phase II clinical trial. J. Dermatol. 52, 872\u2013887 (2025).","journal-title":"J. Dermatol."},{"key":"36295_CR21","first-page":"e70002","volume":"67","author":"M Ozeki","year":"2025","unstructured":"Ozeki, M. et al. Sirolimus treatment for intractable vascular anomalies (SIVA): an open-label, single-arm, multicenter, prospective trial. Pediatr. Int. Off J. Jpn Pediatr. Soc. 67, e70002 (2025).","journal-title":"Pediatr. Int. Off J. Jpn Pediatr. Soc."},{"key":"36295_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12874-023-02017-0","volume":"23","author":"A Allemang-Trivalle","year":"2023","unstructured":"Allemang-Trivalle, A., Leducq, S., Maruani, A. & Giraudeau, B. Designs used in published therapeutic studies of rare superficial vascular anomalies: a systematic literature search. BMC Med. Res. Methodol. 23, 196 (2023).","journal-title":"BMC Med. Res. Methodol."},{"key":"36295_CR23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","volume":"558","author":"Q Venot","year":"2018","unstructured":"Venot, Q. et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 558, 540\u2013546 (2018).","journal-title":"Nature"},{"key":"36295_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jvs.2019.06.217","volume":"71","author":"C Freixo","year":"2020","unstructured":"Freixo, C. et al. Efficacy and safety of sirolimus in the treatment of vascular anomalies: a systematic review. J. Vasc Surg. 71, 318\u2013327 (2020).","journal-title":"J. Vasc Surg."},{"key":"36295_CR25","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3892\/etm.2021.10531","volume":"22","author":"C C\u00eerstoveanu","year":"2021","unstructured":"C\u00eerstoveanu, C. et al. Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns (Case reports). Exp. Ther. Med. 22, 1097 (2021).","journal-title":"Exp. Ther. Med."},{"key":"36295_CR26","doi-asserted-by":"publisher","first-page":"e20153257","DOI":"10.1542\/peds.2015-3257","volume":"137","author":"DM Adams","year":"2016","unstructured":"Adams, D. M. et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 137, e20153257 (2016).","journal-title":"Pediatrics"},{"key":"36295_CR27","first-page":"193","volume":"50","author":"LK Makhija","year":"2017","unstructured":"Makhija, L. K. & Bhattacharya, S. Management of vascular anomalies: review of institutional management algorithm. Indian J. Plast. Surg. Off Publ Assoc. Plast. Surg. India. 50, 193 (2017).","journal-title":"Indian J. Plast. Surg. Off Publ Assoc. Plast. Surg. India"},{"key":"36295_CR28","first-page":"S703","volume":"58","author":"M Hills","year":"1979","unstructured":"Hills, M. & Armitage The two-period cross-over clinical trial. Br. J. Clin. Pharmacol. 58, S703\u2013716 (1979).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"36295_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0895-4356(00)00357-7","volume":"54","author":"B Feldman","year":"2001","unstructured":"Feldman, B., Wang, E., Willan, A. & Szalai, J. P. The randomized placebo-phase design for clinical trials. J. Clin. Epidemiol. 54, 550\u2013557 (2001).","journal-title":"J. Clin. Epidemiol."},{"key":"36295_CR30","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMsm0904209","volume":"361","author":"RB D\u2019Agostino","year":"2009","unstructured":"D\u2019Agostino, R. B. The delayed-start study design. N Engl. J. Med. 361, 1304\u20131306 (2009).","journal-title":"N Engl. J. Med."},{"key":"36295_CR31","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/cts.13488","volume":"16","author":"VEM Harbers","year":"2023","unstructured":"Harbers, V. E. M. et al. Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations - A nationwide trial. Clin. Transl Sci. 16, 781\u2013796 (2023).","journal-title":"Clin. Transl Sci."},{"key":"36295_CR32","doi-asserted-by":"publisher","first-page":"j2835","DOI":"10.1136\/bmj.j2835","volume":"357","author":"N Pandis","year":"2017","unstructured":"Pandis, N., Chung, B., Scherer, R. W., Elbourne, D. & Altman, D. G. CONSORT 2010 statement: extension checklist for reporting within person randomised trials. BMJ 357, j2835 (2017).","journal-title":"BMJ"},{"key":"36295_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/13611260500069947","volume":"27","author":"MR de Villiers","year":"2005","unstructured":"de Villiers, M. R., de Villiers, P. J. T. & Kent, A. P. The Delphi technique in health sciences education research. Med. Teach. 27, 639\u2013643 (2005).","journal-title":"Med. Teach."},{"key":"36295_CR34","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1093\/pubmed\/fdv099","volume":"38","author":"C Cavero-Carbonell","year":"2016","unstructured":"Cavero-Carbonell, C. et al. Consensus on the criteria needed for creating a rare-disease patient registry. A Delphi study. J. Public. Health. 38, e178\u2013e186 (2016).","journal-title":"J. Public. Health"},{"key":"36295_CR35","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0016-3287(69)80025-X","volume":"1","author":"N Dalkey","year":"1969","unstructured":"Dalkey, N. An experimental study of group opinion: the Delphi method. Futures 1, 408\u2013426 (1969).","journal-title":"Futures"},{"key":"36295_CR36","doi-asserted-by":"publisher","first-page":"104420","DOI":"10.1016\/j.ejmg.2022.104420","volume":"65","author":"G Jondeau","year":"2022","unstructured":"Jondeau, G. et al. The VASCERN European reference network: an overview. Eur. J. Med. Genet. 65, 104420 (2022).","journal-title":"Eur. J. Med. Genet."},{"key":"36295_CR37","doi-asserted-by":"crossref","unstructured":"Bodemer, C., Taieb, C., Vidaud, D., Ingen-Housz-Orob, S. & Gene, R. FIMARAD: La fili\u00e8re de sant\u00e9 maladies rares En dermatologie. Ann Dermatol. V\u00e9n\u00e9r\u00e9ol. 145, 423 (2018).","DOI":"10.1016\/j.annder.2018.05.008"},{"key":"36295_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0897-1897(05)80008-4","volume":"5","author":"LL Davis","year":"1992","unstructured":"Davis, L. L. Instrument review: getting the most from a panel of experts. Appl. Nurs. Res. 5, 194\u2013197 (1992).","journal-title":"Appl. Nurs. Res."},{"key":"36295_CR39","doi-asserted-by":"crossref","unstructured":"Mondal, H., Mondal, S., Ghosal, T. & Mondal, S. Using google forms for medical survey: a technical note. Int. J. Clin. Exp. Physiol. 5, 216\u2013218 (2019).","DOI":"10.5530\/ijcep.2018.5.4.26"},{"key":"36295_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","volume":"67","author":"IR Diamond","year":"2014","unstructured":"Diamond, I. R. et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J. Clin. Epidemiol. 67, 401\u2013409 (2014).","journal-title":"J. Clin. Epidemiol."},{"key":"36295_CR41","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.techfore.2012.04.013","volume":"79","author":"HA von der Gracht","year":"2012","unstructured":"von der Gracht, H. A. Consensus measurement in Delphi studies: review and implications for future quality assurance. Technol. Forecast. Soc. Change. 79, 1525\u20131536 (2012).","journal-title":"Technol. Forecast. Soc. Change"},{"key":"36295_CR42","doi-asserted-by":"publisher","first-page":"111333","DOI":"10.1016\/j.jclinepi.2024.111333","volume":"170","author":"B Clyne","year":"2024","unstructured":"Clyne, B. et al. An international modified Delphi process supported updating the web-based \u2018right review\u2019 tool. J. Clin. Epidemiol. 170, 111333 (2024).","journal-title":"J. Clin. Epidemiol."},{"key":"36295_CR43","doi-asserted-by":"crossref","unstructured":"Dietrich, T. J., Mascarenhas, V. V., Cerezal, L. & Afonso, P. D. & Sudo\u0142-Szopi\u0144ska, I. Overview for developing Delphi-based interdisciplinary consensus statements on imaging: pros and cons. J. Ultrason. 24, 1\u20136 (2025).","DOI":"10.15557\/JoU.2024.0015"},{"key":"36295_CR44","unstructured":"Article R1121-1 of the Public Health Code. L\u00e9gifrance (2021). https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000043723460."},{"key":"36295_CR45","doi-asserted-by":"publisher","first-page":"e0002752","DOI":"10.1371\/journal.pgph.0002752","volume":"4","author":"C Mansilla","year":"2024","unstructured":"Mansilla, C., Guyatt, G., Sweetman, A. & Lavis, J. N. Matching the right study design to decision-maker questions: results from a Delphi study. PLOS Glob Public. Health. 4, e0002752 (2024).","journal-title":"PLOS Glob Public. Health"},{"key":"36295_CR46","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1111\/bcp.15441","volume":"88","author":"V Palin","year":"2022","unstructured":"Palin, V. et al. A first step towards best practice recommendations for the design and statistical analyses of pragmatic clinical trials: a modified Delphi approach. Br. J. Clin. Pharmacol. 88, 5183\u20135201 (2022).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"36295_CR47","first-page":"1080","volume":"34","author":"HK Resemann","year":"2018","unstructured":"Resemann, H. K., Clements, S., Griffiths, A. & Sheard, D. Reporting of Delphi methods to achieve consensus on guidelines in rare diseases. Curr. Med. Res. Opin. 34, 1080 (2018).","journal-title":"Curr. Med. Res. Opin."},{"key":"36295_CR48","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.healthpol.2018.09.011","volume":"122","author":"CMW Gaasterland","year":"2018","unstructured":"Gaasterland, C. M. W. et al. The POWER-tool: recommendations for involving patient representatives in choosing relevant outcome measures during rare disease clinical trial design. Health Policy Amst Neth. 122, 1287\u20131294 (2018).","journal-title":"Health Policy Amst Neth."},{"key":"36295_CR49","doi-asserted-by":"publisher","first-page":"e1000393","DOI":"10.1371\/journal.pmed.1000393","volume":"8","author":"IP Sinha","year":"2011","unstructured":"Sinha, I. P., Smyth, R. L. & Williamson, P. R. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLOS Med. 8, e1000393 (2011).","journal-title":"PLOS Med."},{"key":"36295_CR50","unstructured":"European Reference Network for Kidney Diseases. Methodology for the development of clinical consensus statements for rare or Low-Prevalence and complex diseases  (2020)."},{"key":"36295_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","volume":"11","author":"P Nasa","year":"2021","unstructured":"Nasa, P., Jain, R. & Juneja, D. Delphi methodology in healthcare research: how to decide its appropriateness. World J. Methodol. 11, 116\u2013129 (2021).","journal-title":"World J. Methodol."},{"key":"36295_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijnurstu.2025.105119","volume":"168","author":"F Hasson","year":"2025","unstructured":"Hasson, F., Keeney, S. & McKenna, H. Revisiting the Delphi technique - research thinking and practice: a discussion paper. Int. J. Nurs. Stud. 168, 105\u2013119 (2025).","journal-title":"Int. J. Nurs. Stud."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36295-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36295-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36295-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T22:02:32Z","timestamp":1770760952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36295-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36295"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36295-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all respondents prior to their participation in the study. According to Article R1121-1 of the French Public Health Code, studies that do not involve any intervention on the human person, such as opinion surveys, are not subject to the legislation governing research involving human participants (so-called Jard\u00e9 law).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent was acquired from the patients whose images were utilized.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"5638"}}